If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.00
Bid: 30.00
Ask: 30.60
Change: 0.65 (2.19%)
Spread: 0.60 (2.00%)
Open: 30.70
High: 30.70
Low: 30.00
Prev. Close: 29.65
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Oct 2011 17:51

RNS Number : 7512Q
EKF Diagnostics Holdings PLC
24 October 2011
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

EKF Diagnostics Holdings PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

X

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

BlackRock, Inc.

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

20th October 2011

6. Date on which issuer notified:

21st October 2011

7. Threshold(s) that is/are crossed orreached: vi, vii

Holding has gone above 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0031509804

N/A

N/A

N/A

N/A

12,065,651

N/A

4.80%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

CFD

983,049

Nominal

CFD

0.39%

0.39%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

13,048,700

5.19%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

BlackRock Investment Management (UK) Limited - 13,048,700 (5.19%)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

BlackRock International Threshold Reporting Team

14. Contact name:

Andrew Manchester

15. Contact telephone number:

020 7743 5773

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

BlackRock, Inc.

Contact address

(registered office for legal entities)

 

12 Throgmorton Avenue, London, EC2N 2DL

Phone number & email

 

020 7743 5773; andrew.manchester@blackrock.com

Other useful information

(at least legal representative for legal persons)

 

Andrew Manchester

B: Identity of the notifier, if applicable

Full name

 

Contact address

 

Phone number & email

 

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUSSNRABARUAA
Date   Source Headline
22nd Apr 202411:53 amRNSPosting of Annual Report & Notice of AGM
25th Mar 20245:15 pmRNSDirector/PDMR Shareholding
20th Mar 20248:30 amRNSFinal Results
15th Mar 20247:00 amRNSInvestor Presentation – Revised start time
11th Mar 20247:00 amRNSNotice of Results and Investor Presentation
29th Jan 20247:00 amRNSTrading Update
11th Jan 20247:00 amRNSDirector/PDMR Shareholding
3rd Jan 20244:14 pmRNSHolding(s) in Company
29th Nov 20234:55 pmRNSHolding(s) in Company
26th Oct 20237:00 amRNSOpening of new US LS Manufacturing Facility
26th Sep 20237:00 amRNSInterim results
14th Sep 20237:00 amRNSNotice of Results & Investor Presentation
12th Sep 20237:01 amRNSTrading Update
12th Sep 20237:00 amRNSAppointment of CFO
26th Jul 20237:00 amRNSTrading Update
28th Jun 20237:00 amRNSDirectorate Change
20th Jun 20237:00 amRNSEnzyme fermentation capacity expansion progress
1st Jun 202311:07 amRNSHolding(s) in Company
24th May 20237:01 amRNSUpdate re. EKF distribution of shares in Verici Dx
24th May 20237:00 amRNSDistribution of shares in Verici Dx plc
22nd May 20232:52 pmRNSHolding(s) in Company
17th May 202311:50 amRNSResult of AGM and Voting Results
17th May 20237:00 amRNSAGM Statement
3rd May 20237:00 amRNSSuccessful quality management audits
25th Apr 20234:10 pmRNSTotal Voting Rights
21st Apr 20232:30 pmRNSPosting of Annual Report & Notice of AGM
28th Mar 20237:00 amRNSFinal Results
23rd Mar 20237:00 amRNSDisposal of ADL Health
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
21st Feb 20233:31 pmRNSHolding(s) in Company
10th Feb 20233:12 pmRNSHolding(s) in Company
6th Feb 20237:00 amRNSTrading update
9th Jan 20237:00 amRNSChange of Adviser
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSPoint-of-Care update
15th Dec 20224:52 pmRNSHolding(s) in Company
14th Dec 20224:32 pmRNSHolding(s) in Company
6th Dec 20225:30 pmRNSHolding(s) in Company
14th Nov 20225:52 pmRNSHolding(s) in Company
20th Sep 20227:01 amRNSDividend Timetable
20th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
1st Aug 20227:00 amRNSTrading Update
29th Jun 20224:41 pmRNSSecond Price Monitoring Extn
29th Jun 20224:36 pmRNSPrice Monitoring Extension
28th Jun 20223:34 pmRNSHolding(s) in Company
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
20th Jun 20227:00 amRNSDistribution of shares in Verici Dx plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.